| pubmed-article:6684691 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6684691 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:6684691 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:6684691 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:6684691 | pubmed:dateCreated | 1983-11-23 | lld:pubmed |
| pubmed-article:6684691 | pubmed:abstractText | Tin-117m-labeled 23-(trimethylstannyl)-24-nor-5 alpha-cholan-3 beta-ol (2) has been prepared by reaction of trimethyl [117mSn]tin lithium with 3 beta-acetoxy-23-bromo-24-nor-5 alpha-cholane (1). Tin-117m (2) shows pronounced adrenal uptake (2.5% injected dose) in female rats 1 day after injection. Furthermore, the adrenal to liver (9.1:1) and adrenal to blood (33.7:1) ratios are high after this period. The absorbed radiation dose values from [117mSn]2 to human organs have also been estimated by using rat tissue distribution and excretion data. [117mSn]2 is the first reported tissue-specific organic radiopharmaceutical labeled with this nuclide and may have potential as an adrenal imaging agent. | lld:pubmed |
| pubmed-article:6684691 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6684691 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6684691 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6684691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6684691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6684691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6684691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6684691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6684691 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6684691 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:6684691 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:6684691 | pubmed:author | pubmed-author:AmbroseK RKR | lld:pubmed |
| pubmed-article:6684691 | pubmed:author | pubmed-author:ButlerT ATA | lld:pubmed |
| pubmed-article:6684691 | pubmed:author | pubmed-author:KnappF FFFJr | lld:pubmed |
| pubmed-article:6684691 | pubmed:author | pubmed-author:CoffeyJ LJL | lld:pubmed |
| pubmed-article:6684691 | pubmed:author | pubmed-author:CallahanA PAP | lld:pubmed |
| pubmed-article:6684691 | pubmed:author | pubmed-author:FerrenL ALA | lld:pubmed |
| pubmed-article:6684691 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6684691 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:6684691 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6684691 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6684691 | pubmed:pagination | 1535-7 | lld:pubmed |
| pubmed-article:6684691 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:meshHeading | pubmed-meshheading:6684691-... | lld:pubmed |
| pubmed-article:6684691 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6684691 | pubmed:articleTitle | Potential tissue-imaging agents: 23-(trimethyl [117mSn]stannyl)-24-nor-5 alpha-cholan-3 beta-ol. | lld:pubmed |
| pubmed-article:6684691 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6684691 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:6684691 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:6684691 | lld:chembl |
